89 results
424B3
CYTH
Cyclo Therapeutics Inc - Ordinary Shares
21 Nov 23
Prospectus supplement
9:15am
and be unavailable to offset future income tax liabilities, which could adversely affect AMTI’s operating results.
Under Sections 382 and 383 … pre-change tax attributes to offset its post-change taxable income or taxes may be limited. AMTI completed an analysis under Section 382 through
S-4/A
CYTH
Cyclo Therapeutics Inc - Ordinary Shares
20 Nov 23
Registration of securities issued in business combination transactions (amended)
8:50am
in 2036. Realization of these NOLs depends on future income, and there is a risk that AMTI’s existing NOLs could expire unused and be unavailable to offset … to offset its post-change taxable income or taxes may be limited. AMTI completed an analysis under Section 382 through December 31, 2020 and concluded
S-4
CYTH
Cyclo Therapeutics Inc - Ordinary Shares
7 Nov 23
Registration of securities issued in business combination transactions
4:45pm
. Realization of these NOLs depends on future income, and there is a risk that AMTI’s existing NOLs could expire unused and be unavailable to offset … to offset its post-change taxable income or taxes may be limited. AMTI completed an analysis under Section 382 through December 31, 2020 and concluded AMTI
425
EX-2.1
6n15vn
21 Sep 23
Business combination disclosure
4:28pm
8-K
EX-2.1
0ow05x5
21 Sep 23
Cyclo Therapeutics, Inc. and Applied Molecular Transport Inc. Enter into a Definitive Merger Agreement
4:28pm
424B4
y2hz uq9cpepz2
11 Dec 20
Prospectus supplement with pricing info
1:38pm